Alkermes plc (ALKS)

Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$44.94-2.69%As of 2026-11-22 · USD
Last session low $44.83Last session high $46.89
52-week low $27.0052-week high $55.67
Market cap
$7.55B
Sector
Healthcare
P/E (TTM)
117.2x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)57.7In the neutral range (30 to 70)
MACD (12, 26, 9)0.83Below its signal line (0.85); histogram -0.02
Bollinger %B (20, 2)25%Inside the bands (44.01 to 47.79)
SMA 2045.90Price is 2.1% below
SMA 5043.73Price is 2.8% above
SMA 20041.43Price is 8.5% above
ATR (20)3.58% of priceAverage true range per day
52-week position63%In the middle of the 27.00 to 55.67 range

About Alkermes plc

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Insider filings, 90 daysNo purchases and 4 sales (about $698K).
Latest fiscal yearEnded 2025-12-31: revenue of $1.48B and an operating margin of 17.2%.

More in Drug Manufacturers - Specialty & Generic